Navidea Biopharmaceuticals Inc.

05/23/2022 | Press release | Distributed by Public on 05/23/2022 05:34

Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the Tumor Myeloid-Directed Therapies Summit Annual Meeting